Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuya Edahiro

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|November 3, 2018
Improvement of exertional dyspnea and breathing pattern of inspiration to expiration after bronchial thermoplastyKeisuke Miki, Mari Miki, Kenji Yoshimura, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 1, 2018
Sustained Effectiveness of Cilostazol After Endovascular Treatment of Femoropopliteal Lesions: Midterm Follow-up From the Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC) StudyYoshimitsu Soga, Toshimitsu Hamasaki, Ryuya Edahiro, et al.
Journal of Breath Research|January 12, 2018
Exercise tolerance and balance of inspiratory-to-expiratory muscle strength in relation to breathing timing in patients with chronic obstructive pulmonary diseaseKeisuke Miki, Kazuyuki Tsujino, Ryuya Edahiro, et al.
Plos One|August 29, 2018
Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective studyYukihiro Yano, Hiroyuki Kurebe, Ryuya Edahiro, et al.
Respirology (Carlton, Vic.)|March 6, 2019
Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumoniasToru Arai, Hiroshi Kida, Yoshitaka Ogata, et al.
Plos One|August 1, 2019
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in JapanRyuya Edahiro, Masaki Kanazu, Hiroyuki Kurebe, et al.
Internal Medicine (Tokyo, Japan)|October 19, 2018
Three Cases of Idiopathic Diffuse Pulmonary OssificationRyuya Edahiro, Hiroyuki Kurebe, Saeko Nakatsubo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patientsJonas Nørskov Søndergaard, Janyerkye Tulyeu, Ryuya Edahiro, et al.
Ebiomedicine|January 23, 2025
Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugatesYuichi Adachi, Kotaro Miyake, Kika Ohira, et al.
Nature Communications|October 11, 2023
Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitisMasayuki Nishide, Kei Nishimura, Hiroaki Matsushita, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|November 3, 2018
Improvement of exertional dyspnea and breathing pattern of inspiration to expiration after bronchial thermoplastyKeisuke Miki, Mari Miki, Kenji Yoshimura, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 1, 2018
Sustained Effectiveness of Cilostazol After Endovascular Treatment of Femoropopliteal Lesions: Midterm Follow-up From the Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC) StudyYoshimitsu Soga, Toshimitsu Hamasaki, Ryuya Edahiro, et al.
Journal of Breath Research|January 12, 2018
Exercise tolerance and balance of inspiratory-to-expiratory muscle strength in relation to breathing timing in patients with chronic obstructive pulmonary diseaseKeisuke Miki, Kazuyuki Tsujino, Ryuya Edahiro, et al.
Plos One|August 29, 2018
Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective studyYukihiro Yano, Hiroyuki Kurebe, Ryuya Edahiro, et al.
Respirology (Carlton, Vic.)|March 6, 2019
Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumoniasToru Arai, Hiroshi Kida, Yoshitaka Ogata, et al.
Plos One|August 1, 2019
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in JapanRyuya Edahiro, Masaki Kanazu, Hiroyuki Kurebe, et al.
Internal Medicine (Tokyo, Japan)|October 19, 2018
Three Cases of Idiopathic Diffuse Pulmonary OssificationRyuya Edahiro, Hiroyuki Kurebe, Saeko Nakatsubo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patientsJonas Nørskov Søndergaard, Janyerkye Tulyeu, Ryuya Edahiro, et al.
Ebiomedicine|January 23, 2025
Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugatesYuichi Adachi, Kotaro Miyake, Kika Ohira, et al.
Nature Communications|October 11, 2023
Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitisMasayuki Nishide, Kei Nishimura, Hiroaki Matsushita, et al.
Pageof 7